Session Title: Pediatric Rheumatology – Pathogenesis and Genetics - Poster
Session Type: ACR Poster Session C
Session Time: 9:00AM-11:00AM
Background/Purpose: Myeloid differentiation primary response 88 (MyD88) is a critical adaptor protein that connects Toll-like and IL-1 receptor signaling to activation of NF-κB. Germline loss-of-function mutations in MyD88 cause immunodeficiency, while somatic gain-of-function mutations have been linked to lymphoma. We investigated a child with a progressively destructive small-to-medium joint polyarticular JIA since the age of 2 with persistent neutrophil predominant synovial infiltrates.
Methods: We evaluated the patient and family members by whole exome sequencing (WES), peripheral blood immunophenotyping, and phosphorylated-STAT3 (p-STAT3) quantitation. Functional studies in monocytes and dermal fibroblasts included gene/protein expression, quantitation of neutrophil chemotaxis, and siRNA-mediated knockdown of MyD88 and NF-κB subunit p65 (p65). Wild type or S222R MyD88-GFP fusion proteins were re-expressed in MyD88-deficient THP-1 cells. NF-κB activity in THP-1 cells was measured via secreted embryonic alkaline phosphatase reporter assay.
Results: WES revealed a de novo heterozygous missense mutation in MYD88(c.666T>G, p.Ser222Arg), which was confirmed by Sanger sequencing in both peripheral leukocytes and dermal fibroblasts. Immunophenotyping showed an absence of CD16+ monocytes, an expansion of CD4+ Th17 T cells, and the presence of a previously uncharacterized CD123+CD11c+ dendritic cell population, as well as markedly increased basal and stimulated p-STAT3 in monocytes and T and B lymphocytes in the patient. Peripheral monocytes exhibited a baseline interferon gene expression signature and increased expression of neutrophil and monocyte chemokines. Fibroblasts exhibited significantly greater baseline expression of CXCL chemokines compared to controls, which abated upon MyD88 or p65 knockdown. Re-expression of wild type or S222R MyD88-GFP fusion protein in MyD88-knockout THP-1 cells demonstrated increased NF-κB activation at baseline and with stimulation in S222R-MyD88-expressing cells.
Conclusion: This is the first description of a de novo germline MyD88 mutation associated with severe polyarticular JIA. The gain-of-function effects demonstrated in the patient’s hematopoietic and non-hematopoietic cells offer a plausible mechanism for arthritis and support a role for single gene defects contributing to extreme JIA phenotypes.
To cite this abstract in AMA style:Sikora KA, Bennett JR, Deng Z, Tsai WL, Brundidge A, Navid F, Layh-Schmitt G, Hanson E, Gadina MG, Staudt LM, Griffin TA, Colbert RA. Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88 [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/severe-juvenile-arthritis-associated-with-a-de-novo-gain-of-function-germline-mutation-in-myd88/. Accessed December 2, 2020.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/severe-juvenile-arthritis-associated-with-a-de-novo-gain-of-function-germline-mutation-in-myd88/